Biological Functions of Haptoglobin - New Pieces to an Old Puzzle

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 9, 1997, Pages 647-654

  Dobryszycka, Wanda ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CHOLESTEROL; HAPTOGLOBIN; HEMOGLOBIN;

ADIPOSE TISSUE; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER; CRYSTALLIZATION; DISEASE SEVERITY; GENETIC POLYMORPHISM; INFECTION; INFLAMMATION; LIGAND BINDING; LUNG; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; RETICULOENDOTHELIAL SYSTEM; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; GENE EXPRESSION REGULATION; HAPTOGLOBINS; HEMOGLOBINS; HUMANS; INFECTION; INFLAMMATION; LEUKOCYTES; PHENOTYPE; PROTEIN BINDING;

EID: 0030720049     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.9.647     Document Type: Article

References (81)

1. Pintera J. The biochemical, genetic, and clinicopathologic aspects of haptoglobin. In: Jensen KG, Killman S-A, editors. Munksgaard, Copenhagen: Series Haematol 1971; 4: 1-183.
2. Putnam FW, Haptoglobin. In: Putnam FW, editor. The plasma proteins, structure, function, and genetic control. New York: Academic Press, 1975; 2: 1-50.
3. Javid J. Human haptoglobins. Current Topics Hematol 1978; 1: 151-192.
4. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982; 12: 189-261.
5. Dobryszycka W. Haptoglobin: retrospectives and perspectives. In: Mackiewicz A, Kushner I, Baumann H, editors. Acute phase proteins: molecular biology, biochemistry, and clinical applications. Boca Raton, Ann Arbor, London, Tokyo: CRC Press, 1993: 185-206.
6. Okazaki T, Yanagisawa Y, Nagai T. Determination of intermediates of hemoglobin-haptoglobin complex of haptoglobin polymers by “crossed hemoglobin electrophoresis”. Anal Bio-chem 1996; 239: 123-129.
7. Mann AC, Record CO, Self CH, Turner GA, Monosacharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin Chim Acta 1994; 227: 69-78.
8. Maeda N. DNA polymorphisms in the controlling region of the human haptoglobin genes: a molecular explanation for the haptoglobin 2-1 modified phenotype. Am J Hum Genet 1992; 49: 158-166.
9. Maries SL, McAlpine PJ, Zelinski T, Phillips S, Maeda N, Greenberg CR, Identification of an uncommon haptoglobin type using DNA and protein analysis. Hum Genet 1993; 92: 364-366.
10. Langlois MR, Delanghe JR, Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42: 1589-1600.
11. Javid J. The effect of haptoglobin polymer size on hemoglobin binding capacity. Vox Sang 1965; 10: 320-325.
12. Gutteridge JMC. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987; 917: 219-223.
13. Lange V. Der Haptoglobin Polymorphismus-nicht nur eine genetische Markierungshilfe. Anthropol Anz 1992; 50: 281-302. Cited acc. to 1. c. (8).
14. Ramji DP, Cortese R, Ciliberto G. Regulation of C-reactive protein, haptoglobin and hemopexin gene expression. In: Ma-ciewicz A, Kushner I, Baumann H, editors. Acute phase proteins: molecular biology, biochemistry, and clinical applications. Boca Raton, Ann Arbor, London, Tokyo: CRC Press, 1993: 365-95.
15. Baumann H, Jahreis GP, Morelia KK, Interaction of cytokine-and glucocorticoid-response elements of acute-phase plasma protein genes. J Biol Chem 1990; 265: 22275-22281.
16. Petrović M, Bogojević D, Grigorov I, Sevaljevic L. The DNA binding affinity of rat liver nucleoproteins to the regulatory elements of the haptoglobin and α2-marcroglobulin genes. Cell Biol Int 1995; 19: 967-72.
17. Friedrichs WE, Navarijo-Ashbaugh AL, Bowman BH, Yang F. Expression and inflammatory regulation of haptoglobin gene in adipocytes. Biochem Biophys Res Commun 1995; 209: 250-256.
18. Yang F, Friedrichs WE, Navarijo-Aschbaugh AL, De Graffen-ried LA, Bowman BH, Coalson JJ, Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung. Lab Invest 1995; 73: 433-40.
19. Buchanan GR, Holtkamp CA, Johnson A. Reduced serum haptoglobin values in hemophiliacs receiving monoclonally purified Factor VIII concentrates. Am J Hematol 1990; 33: 234-237.
20. Lewis LA, Dyer DW, Identification of an iron-regulated outer membrane protein of Neisseria meningitidis involved in the utilization of hemoglobin complexed with haptoglobin. J Bac-teriol 1995; 177: 1293-1306.
21. Edwards DH, Griffith TM, Ryley HC, Henderson AH, Hapto-globin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res 1986; 20: 549-556.
22. Jayle MF, Méthode de dosage de l'haptoglobine sérique. Bull Soc Chim Biol 1951; 33: 876-880.
23. Rafowicz S, Lavergne J-M. Determination rapide des groupes d'haptoglobine par électrophorèse en gel d'agarose. Ann Biol Clin 1974; 32: 439-441.
24. Dobryszycka W, Katnik I. Interaction of haptoglobin with Con A and Wheat Germ Agglutinin. Basic research and clinical applications. In: Breborowicz J, Mackiewicz A, editors. Affinity electrophoresis: principles and applications. Boca Raton, Ann Arbor, London: CRC Press. 1992; 221-225.
25. Mallet B, Franc JL, Miquel M, Arnaud C. Effects of severe bums of glycan microheterogeneity of four acute phase proteins. Clin Chim Acta 1987; 167: 247-57.
26. Douma GJ, Van Dalen A. An evaluation of the diagnostic value of haptoglobin and transferrin levels in serum. Z Klin Chem Klin Biochem 1974; 12: 474-476.
27. Elson EC, Quantitative determination of serum haptoglobin. Am J Clin Pathol 1974; 62: 655-663.
28. Khayam-Bashi H, Feldhammer P, Tyler G. Determination of serum haptoglobin concentration by a laser-immunonephelo-metric procedure. Clin Chem 1977; 23: 1137.
29. Lämmler C, Guszczynski T, Dobryszycka W. Further characterization of haptoglobin binding to streptococci of serological group A. Zbl Bakt Hyg 1988; A269: 454-459.
30. Katnik I, Dobryszycka W. Enzyme immunoassay to measure low levels of haptoglobin in biological fluids. J Immunoassay 1990; 11: 503-517.
31. Katnik I, Dobryszycka W. Development of concanavalin A enzyme immunosorbent assay for glycated haptoglobin using polyclonal and monoclonal antibodies. J Immunoassay 13; 1992: 145-162.
32. Oh SK, Kim SH, Abbruzzi G, Adler WH, Tauber AI, Quantitative differentiation of the haptoglobin-related gene product from haptoglobin in human plasma: a possible test for tumor-associated antigen. Hybridoma 1992; 11: 1-12.
33. Dobryszycka W. Clinical significance of haptoglobin measurements (Polish text). Diagnostyka Laboratoryjna 1987; 23: 177-185.
34. Consensus of a Group of Professional Societies and Diagnostic Companies on Guidelines for Interim Reference Ranges for 14 Proteins in Serum Based on the Standardization against the IFCC/BCR/CAP Reference Material (OMR 470). Eur J Clin Chem Clin Biochem 1966; 34: 517.
35. Maes M, Cooreman W, Delanghe J, Scharpe S, Wauters A, Neels H, et al. Components of biological variation in plasma haptoglobin: relationships to plasma fibrinogen and immune variables, including interleukin-6 and its receptor. Clin Chim Acta 1995; 239: 23-35.
36. Bacq Y, Schillio Y, Brechot J-F, De Muret A, Dubois F, Metman E-H. Diminution de l'haptoglobinémie chez les malades atteints d'hepatite chronique virale C. Gastroenterol Clin Biol 1993; 17: 364-369.
37. Reynolds TL, Khan MA, van der Linden S., Cleveland RP, Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin. Ann Rheum Dis 1991; 50: 154-157.
38. Dobryszycka W, Gerber J, Zuwala-Jagiello J, Ujec M. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma. Arch Immun Ther Exp 1991; 39: 41-50.
39. Fish RG, Gill TS, Adams M, Kerby I. Serum haptoglobin and α1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients. Eur J Cancer Clin Oncol 1984; 20: 625-630.
40. Solerte SB, Adamo S, Viola C, Schianca GPC, Crippa A. Ferrari E. Acute-phase protein reactants pattern and a2-macroglobulin in diabetes mellitus. Pathophysiological aspects in diabetic microangiopathy. Ric Clin Lab 1984; 14: 575-579.
41. Bernard DR, Langlois MR, Delanghe JR, DeBuyzere ML, Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction. Eur J Clin Chem Clin Biochem 1997; 35: 85-88.
42. Eversole JL, Machen RL, Steffen MJ, Willmann DE, Systemic acute phase reactants, C-reactive protein and haptoglobin in adult periodontitis. Clin Exp Immunol 1997; 107: 347-352.
43. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. J Am Med Assoc 1980; 243: 1909-1911.
44. Warkentin DL, Marchand A, Van Lente F. Serum haptoglobin concentrations in concurrent hemolysis and acute phase reaction. Clin Chem 1987; 33: 1265-1268.
45. Shioi K, Nagata Y, Mase T, Aoyama T, Katoh S, Tsuchioka H. Evaluation of intravascular hemolysis by haptoglobin administration after prosthetic valve replacement. Japan Circuí J 1993; 57: 322-327.
46. Maes M, Delanghe J, Schärpe S, Meitzer HY, Cosyns P, Suy E, Bosnians E. Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiatry 1994; 151: 112-116.
47. Fañanás L, Moral P, Gutiérrez B, Guillamat R, Vallès V, Campillo M, et al. Haptoglobin phenotypes and gene frequencies in bipolar disorder: an association study in family-history subgroups. Hum Hered 1997; 47: 27-32.
48. Maes M, Lambrechts J, Bosnians E, Jacobs J, Suy E, Vanderv-orst C, et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 1992; 22: 45-53.
49. Maes M, Schärpe S, Meitzer HY, Gosyns P. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry 1993; 34: 690-701.
50. Maes M, Schärpe S, Cosyns O, Meitzer H. Relationships between basal hypothalamic-pituitary-thyroid-axis activity and plasma haptoglobin levels in depression. J Psychiatr Res 1994; 28: 123-134.
51. Chambers W, Thompson S, Skillen AW, Record CO, Turner GA, Abnormally fucosylated haptoglobin as a marker for liver disease but not excessive alcohol consumption or non-alcoholic liver disease. Clin Chim Acta 1993; 219: 177-182.
52. Thompson S, Dargan E, Griffiths ID, Kelly CA, Turner GA, The glycosylation of haptoglobin in rheumatoid arthritis. Clin Chim Acta 1993; 220: 107-114.
53. Hashizumi M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988; 6: 340.
54. Tsuda H, Shirono K, Shimizu K. Is prophylactic haptoglobin infusion in peripheral blood stem cell transplantation clinically useful? Eur J Haematol 1995; 55: 214-215.
55. Teige B, Olaisen B, Pedersen L, Teisberg P. Forensic aspects of haptoglobin: electrophoretic patterns of haptoglobin allotype products and an evaluation of typing procedure. Electrophoresis 1988; 9: 384-392.
56. Peacock AC, Serum haptoglobin type and leukemia: association with possible etiological significance. J Natl Cancer Inst 1966; 36: 631-639.
57. Saha N, Liu Y, Tay JSH, Basair J, Cho CH, Association of haptoglobin types with serum lipids and apolipoproteins in a Chinese population. Clin Genet 1992; 42: 57-61.
58. Fan C, Nylander P-D, Sikstrom C, Thunell M. Orosomucoid and haptoglobin types in patients with sarcoidosis. Exp Clin Immunogenet 1995; 12: 31-35.
59. Zhao H, Zhang G. Haptoglobin groups and cirrhosis of the liver. Hum Hered 1993; 43: 134-136.
60. Louagie HK, Brouver JT, Delanghe JR, De Buyzere ML, Ler-oux-Roels GG, Haptoglobin polymorphism and chronic hepatitis C. J Hepatol 1996; 25: 10-14.
61. Delanghe JR, Duprez DA, De Buyzere ML, Bergez BM, Callens BY, Leroux-Roels GG, et al. Haptoglobin polymorphism and complications in established essential arterial hypertension. J Hypertension 1993; 11: 861-867.
62. Moreira HW, Naoum PC, Serum haptoglobin types in patients with hemoglobinopathies. Hereditas 1990; 113: 227-231.
63. Louagie HK, Brouver JT, Desombere I, De Buyzere ML, Hauser P, Leroux-Roels GG, Haptoglobin polymorphism and the immune response after hepatitis B vaccination. Vaccine 1993; 11: 1188-1190.
64. Beisembaeva RU, Mursagalieva AT, Dzhurmalieva LM, Shaikenov TE, Mevkh AT, Identification of haptoglobin as an endogenous inhibitor of prostaglandin A synthase in the cytosol fraction of primary cells from sheep vesicular glands. FEBS Lett 1990; 269: 125-127.
65. Koj A. Biological functions of acute-phase proteins and the cytokines involved in their induced synthesis. In: Reutter W, Heinrich PC, Popper H, Keppler D, Arias IM, Landmann L, editors. Modulation of liver cell expression. Falk symposium 43, Lancaster, Boston, The Hague, Dordrecht: MTP Press Limited, 1986: 331-341.
66. Köhler W, Prokop O. Relationship between haptoglobin and Streptococcus pyogenes T4 antigens. Nature 1978; 271: 373.
67. Kim IK, Lee JH, Kim HS, Kwon OJ, Shim BS, A novel function of haptoglobin: haptoglobin-haemoglobin complex induces apoptosis of hepatocarcinomatous Hep 3B cells. Scand J Clin Lab Invest 1995; 55: 529-535.
68. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK, Identification of haptoglobin as angiogenic factor in sera of patiens with systemic vasculitis. J Clin Invest 1993; 91: 977-985.
69. Yamashita G, Corradini SG, Secknus R, Takabayashi A, Williams C, Hays L, et al. Biliary haptoglobin, a potent promotor of cholesterol crystallization at physiological concentrations. J Lipid Res 1995; 36: 1325-1333.
70. Smith AB, Esko JD, Hajduk SL, Killing of trypanosomes by the human haptoglobin-related protein. Science 1995; 268: 284-286.
71. Tomlison S, Raper J. The lysis of Trypanosoma brucei brucei by human serum. Nature Biotech 1996; 14: 717-721.
72. Lemer UH, Fröhlander N. Haptoglobin-stimulated bone resorption in neonatal mouse calvarial bones in vitro. Arthritis Rheum 1992; 35: 587-591.
73. Fröhlander N, Ljunggren O, Lemer UH, Haptoglobin synergis-tically potentiates bradykinin and thrombin induced prostaglandin biosynthesis in isolated osteoblasts. Biochem Biophys Res Commun 1991; 178: 343-351.
74. Wagner L, Gessl A, Baumgartner Parzer S., Base W, Waldhausl W, Pasternack MS, Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J Immunol 1996; 156: 1989-1996.
75. El Ghmati SM, Van Hoeyveld EM, Van Strijp JAG, Ceuppens JL, Stevens EAM. Identification of haptoglobin as an alternative ligand for CDllb/CD18. J Immunol 1996; 156: 2542-2552.
76. Hanasaki K, Powell LD, Varki A. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem 1995; 270: 7543-7550.
77. Katnik I, Goodarzi MT, Turner GA, An improved ELISA for the determination of sialyl Lewisx structures on purified glyco-conjugates. Glycoconjugate J 1996; 13: 1-5.
78. Tabak S, Lev A, Valansi C, Aker O, Shalitin C. Transcriptionally active haptoglobin-related (Hpr) gene in hepatoma G2 and leukemia molt-4 cells. DNA Cell Biol 1996; 15: 1001-1007.
79. Oh SK, Very DL, Ettinger R, Walker J, Giampaolo C, Bernardo J. Monoclonal antibody to SER immune suppressor detects polymeric forms of haptoglobin. Hybridoma 1989; 8: 449-466.
80. Elg SA, Carson LF, Fowler JM, Twiggs LB, Moradi MM, Ascites levels of haptoglobin in patients with ovarian cancer. Cancer 1993; 71: 3938-3941.
81. Katnik I, Jadach J, Kmieciak K, Gerber J, Dobryszycka W. Measurements of haptoglobin by the reaction with concana-valin A in sera of patients with ovarian tumours. Eur J Clin Chem Clin Biochem 1995; 33: 727-732.